Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 17, 2015

View Archived Issues

Biophysical mechanisms causing susceptibility to tinnitus identified

GW Pharmaceuticals reports PoC data for cannabidiol in schizophrenia

BriaCell to develop companion diagnostic to BriaVax

Daiichi Sankyo and Translational Sciences to develop thrombus dissolving agent

NecroX-7 reduces renal ischemia-reperfusion injury in vivo

QRLS1 mutations identified as a cause of infantile mitochondrial disease

Opdivo receives FDA breakthrough therapy designation for renal cell carcinoma

Intra-Cellular Therapies reports topline data from phase III trial of ITI-007

Nuvo Research to split into commercial healthcare and biotech development companies

Malaria vaccine shows promising preliminary safety results

ClearLight Diagnostics licenses Stanford IP for tissue processing and imaging technologies

Contextual Genomics and National Cancer Institute of Canada enter collaboration

Genfit develops circulating miRNA diagnostic kit for NASH

Interim update from Chinese trial of BTI-320 in prediabetic patients

InSite Vision enters merger agreement with Sun Pharma, terminates QLT merger agreement

Researchers identify novel mutation in GBE1 gene in a GSD-IV patient

Novo Nordisk reports stable glucagon analogues

AbbVie plans to proceed to phase III evaluation of elagolix

Bristol-Myers Squibb reports HIV integrase inhibitor macrocycles

BioRestorative collaborates with University of Pennsylvania to research brown adipose biology

Chinese team presents anti-HCV agents

Amgen and Xencor collaborate in cancer immunotherapy and inflammation

Japan Tobacco presents mPGES-1 inhibitors

Trulicity launched in Japan

Edison Pharmaceuticals develops agents for pervasive developmental disorders

Viamet's VT-1129 obtains FDA's QIDP designation for cryptococcal meningitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...